3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
CNS
2
Other solid neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Sarcoma
17
Glioblastoma
10
Brain Neoplasms
10
Gliosarcoma
9
Rhabdomyosarcoma
7
Osteosarcoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Sarcoma, Ewing
5
Recurrence
5
Leukemia, Myeloid, Acute
5
Dendritic Cell Sarcoma, Interdigitating
5
Burkitt Lymphoma
5
Astrocytoma
5
Oligodendroglioma
4
Myeloproliferative Disorders
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Hodgkin Disease
4
Glioma
4
Rhabdoid Tumor
3
Primary Myelofibrosis
3
Neurofibrosarcoma
3
Neuroblastoma
3
Interventions
Temozolomide
14
Filgrastim
13
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
Carboplatin
7
Peripheral Blood Stem Cell Transplantation
6
Irinotecan
6
Granulocyte Colony-Stimulating Factor
6
Etoposide
6
X-Rays
5
Topotecan
5
Thiotepa
5
Phantoms, Imaging
5
Busulfan
5
Biopsy
5
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Melphalan
4
Ifosfamide
4
sargramostim
3
palbociclib
3
olaparib
3
etoposide phosphate
3
Surgical Procedures, Operative
3
Paclitaxel
3
ulixertinib
2
trioctyl phosphine oxide
2
tipifarnib
2
tazemetostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Sirolimus
×
Sarcoma
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled